<DOC>
	<DOCNO>NCT01658540</DOCNO>
	<brief_summary>The primary purpose study assess safety efficacy Drug Eluting Balloon ( DEB ) technology treatment Superficial Femoral Artery ( SFA ) ischemic obstructive vascular disease patient present long lesion . As secondary aim study go explore treatment effect number procedural clinical endpoint order collect information design future comparative effectiveness study .</brief_summary>
	<brief_title>Drug Eluting Balloon ( DEB ) Long Lesions Superficial Femoral Artery ( SFA ) Ischemic Vascular Disease</brief_title>
	<detailed_description>The study aim collect preliminary safety efficacy data relate use Drug Eluting Balloon ( DEB ) technology treatment symptomatic Superficial Femoral Artery ( SFA ) ischemic vascular disease patient present long lesion . The present clinical evaluation intend prospective observational data collection patient treatment full accordance institution standard practice utilize approve ( CE mark ) DEB currently available market .</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Documented ischemic , symptomatic arterial disease femoralpopliteal artery accord Rutherford Category 2 , 3 4 ; Target lesion consist single solitary multiple adjacent de novo restenotic lesion ( noninstent ) diameter stenosis ≥ 70 % visual estimate cumulative lesion length ≥ 15 cm ; Target vessel superficial femoral artery and/or proximal popliteal artery ( knee ) ; Life expectancy &gt; 1 year Investigator 's opinion ; Written inform consent . Exclusion criterion : Given observational nature study , studyspecific clinical exclusion criterion apply : Patient unwilling unlikely comply FU schedule ; Administration local systemic thrombolytic therapy within 48 hour prior index procedure ; Known allergy sensitivities heparin , aspirin , anticoagulant/antiplatelet therapy , and/or paclitaxel ; Additional plan cardiac peripheral percutaneous surgical intervention include CABG within 30 day follow study procedure ; 15 cm long inflow lesion ( ≥50 % DS ) occlusion ( length ) ipsilateral Iliac artery ; Failure successfully treat &lt; 15 cm long inflow lesion ipsilateral Iliac artery</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Drug Eluting Balloon ( DEB ) technology</keyword>
	<keyword>long SFA lesion disease</keyword>
</DOC>